|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Clinical approaches to non-alcoholic fatty liver disease显示文摘Non-alcoholic fatty liver disease(NAFLD)ranges from simple steatosis to nonalcoholic steatohepatitis(NASH),leading to fibrosis and potentially cirrhosis,and it is one of the most common causes of liver disease worldwide.NAFLD is associated with other medical conditions such as metabolic syndrome,obesity,cardiovascular disease and diabetes.NASH can only be diagnosed through liver biopsy,but noninvasive techniques have been developed to identify patients who are most likely to have NASH or fibrosis,reducing the need for liver biopsy and risk to patients.Disease progression varies between individuals and is linked to a number of risk factors.Mechanisms involved in the pathogenesis are associated with diet and lifestyle,influx of free fatty acids to the liver from adipose tissue due to insulin resistance,hepatic oxidative stress,cytokines production,reduced very low-density lipoprotein secretion and intestinal microbiome.Weight loss through improved diet and increased physical activity has been the cornerstone therapy of NAFLD.Recent therapies such as pioglitazone and vitamin E have been shown to be beneficial.Omega 3 polyunsaturated fatty acids and statins may offer additional benefits.Bariatric surgery should be considered in morbidly obese patients.More research is needed to assess the impact of these treatments on a long-term basis.The objective of this article is to briefly review the diagnosis,management and treatment of this disease in order to aid clinicians in managing these patients. | Katherine JP Schwenger Johane P Allard | 2014 | World Journal of Gastroenterology2014，20，7： | 21 |
| 2 | Von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis显示文摘 | Monika Ferlitsch Thomas Reiberger Matthias Hoke Petra Salzl Bernadette Schwengerer Gregor Ulbrich Berit Anna Payer Michael Trauner Markus Peck‐Radosavljevic Arnulf Ferlitsch | 2012 | Hepatology2012，，4： | 2 |
| 3 | Real-time contrast-enhanced sonography of renal transplant recipients predicts chronic allograft nephropathy 显示文摘 | Schwenger V Korosoglou G Hinkel UP | 2006 | Am J Transplant2006，6，： | 1 |
| 4 | Treatment of life-threatening multiresistant staphylococcal and enterococcal infections in patients with end-stage renal failure with quinupristin/dalfopristin:preliminary report显示文摘 | Schwenger V Mundlein E Dagrosa EE | 2002 | Infection2002，30，5： | 1 |
| 5 | Real-time contrast- enhanced sonography of renal transplant recipients predicts chronic allograft nephropathy 显示文摘 | Schwenger V Korosoglou G Hinkel UP | 2006 | Am J Transplant2006，6，3： | 1 |
| 6 | Detection of the Homozygous Recessive Genotype for Deficiency of Uridine Monophopthate Synthase by DNA Typing among Bovine Embryos Produced in Vitro显示文摘 | B Schwenger | 1994 | The Journal of Reproduction and Fertility1994，100，： | 1 |
| 7 | Hypertension after renal transplantation显示文摘 | Schwenger V Zeier M Ritz E | 2001 | Ann Transplant2001，6，4： | 1 |
| 8 | CRP levels in autoimmunedisease can be specified by measurement of procalcitonin显示文摘 | Schwenger V Sis J Breitbart A | 1998 | In-fection1998，26，5： | 1 |
| 9 | Advanced glycation end products (AGEs) as uremic toxins显示文摘 | Schwenger V Zeler M Henle T | 2001 | Food Nahrung2001，45，： | 1 |
| 10 | DUMPS cattle carry apoint mutation in the uridine monophos-phate synthase gene显示文摘 | SCHWENGER B SCHOBER S SIMON D | 1993 | Genomics1993，16，： | 1 |
| 11 | De-tection of the homozygous recessive genotype for defi-ciency of uridine monophosphate synthase by DNA typing among bovine embryos produced in vitro显示文摘 | SCHWENGER B I TAMMERN AURICH C | 1994 | J Reprod Fertil1994，100，： | 1 |
| 12 | Sustained low efficiency dialysis using a single-pass batch system in acute kidney injury-a randomized interventional trial:the renal replacement therapy study in intensive care unit patients显示文摘 | Schwenger V Weigand MA Hoffmann O | | 0，，： | 1 |
| 13 | Gastrointestinal hemorrhage in hemodialysis patients显示文摘 | Furkert JD Zeier M Schwenger V | 2008 | Z Gastroenterol2008，46，11： | 1 |
| 14 | Hypertension after renal transplamation显示文摘 | Schwenger V Zeier M Ritz E | 2001 | Curr Hypertens Rep2001，3，5： | 1 |
| 15 | Interaction of calcitonin gene-related peptide, nitric oxide and histamine release in neurogenic blood flow and afferent activation in the rat cranial dura mater显示文摘 | Schwenger N Dux M de Col R | 2007 | Cephalalgia2007，27，6： | 1 |
| 16 | Realtime contrast-enhanced sonography of renal transplant recipients predicts chronic allograft nephropathy显示文摘 | Schwenger V Korosoglou G Hinkel UP | | 0，，03： | 1 |
| 17 | Anithypertensive therapy in renal patients-benefits and difficulties显示文摘 | Schwenger V Zeier M Ritz E | 1999 | Nephron1999，83，： | 1 |
| 18 | CRP levels in autoimmune disease can be specified by measurement of procalcitonin显示文摘 | Schwenger V Sis J Breitbart A | 1998 | Infection1998，26，5： | 1 |
| 19 | CRP levels in autoimmune disease can be specified by measurement of procalcitonin显示文摘 | Schwenger V Sis J Breitbart A | 1998 | Infection1998，26，5： | 1 |
| 20 | GDP and AGE Receptors: Mechanisms of Peri- toneal Damage显示文摘 | Schwenger V | 2006 | Contrib Nephrol2006，150，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员